Company Filing History:
Years Active: 2002
Title: Nancy Ruffing: Innovator in Antibody Research
Introduction
Nancy Ruffing is a notable inventor based in Somerville, Massachusetts. He has made significant contributions in the field of biopharmaceuticals, particularly through his patent on anti-CCR4 antibodies.
Latest Patents
Ruffing holds a patent titled "Anti-CCR4 antibodies and methods of use therefor." This invention pertains to an antibody or its functional fragment that specifically binds to the mammalian CC-chemokine receptor 4 (CCR4). It effectively blocks the binding of a ligand to the receptor. Furthermore, the patent encompasses methods for inhibiting the interaction of cells expressing mammalian CCR4 with its ligand, extending the utility of these antibodies in various research, therapeutic, prophylactic, and diagnostic applications.
Career Highlights
He is currently employed at Millennium Pharmaceuticals Limited, a leading company in the biopharmaceutical sector. Ruffing’s work there centers on developing innovative treatments that utilize cutting-edge antibody technologies.
Collaborations
Throughout his career, Ruffing has collaborated with notable colleagues including Lijun Wu and David P. Andrew. Their collective efforts have advanced the understanding and application of CCR4-related therapies.
Conclusion
Nancy Ruffing exemplifies the spirit of innovation in the field of biotechnology. His pivotal patent has the potential to transform therapeutic approaches for diseases linked to CCR4 interactions, illustrating the impact of inventive minds in advancing healthcare solutions.